ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2021
Screening for
Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 37 citations in OpenAlex.
- Review
- Active Screening forJournal of fungi (Basel, Switzerland) · 2026Review
- Prospective surveillance of Candida auris and assessment of diagnostic approaches in a Belgian hospital.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Article
- Diagnostic Approaches forMicroorganisms · 2025Review
- Risk Factors forInfection and drug resistance · 2025Article
- Is routine screening forIranian journal of microbiology · 2024Article
- Article
- The laboratory investigation, management, and infection prevention and control ofJournal of medical microbiology · 2024Review
- Review
- Enhancing ICUFrontiers in cellular and infection microbiology · 2024Article
- Impact of In-houseOpen forum infectious diseases · 2023Article
- Candida auris admission screening pilot in select units of New York City health care facilities, 2017-2019.American journal of infection control · 2023Article
- Enablers ofCurrent medical mycology · 2023Review
- Review
- Navigating the New Reality: A Review of the Epidemiological, Clinical, and Microbiological Characteristics ofJournal of fungi (Basel, Switzerland) · 2023Review
- First Patient-to-Patient Intrahospital Transmission of Clade I Candida auris in France Revealed after a Two-Month Incubation Period.Microbiology spectrum · 2022Article
- Population genomic analyses reveal evidence for limited recombination in the superbugComputational and structural biotechnology journal · 2022Article
- TwoJournal of fungi (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors at 7 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.